These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 16521119)
1. Investigation of the phase diagrams of chiral praziquantel. Liu Y; Wang X; Wang JK; Ching CB Chirality; 2006 May; 18(4):259-64. PubMed ID: 16521119 [TBL] [Abstract][Full Text] [Related]
2. Physicochemical properties, binary and ternary phase diagrams of ketoprofen. Hong Lu Y; Bun Ching C Chirality; 2004 Oct; 16(8):541-8. PubMed ID: 15290690 [TBL] [Abstract][Full Text] [Related]
3. Structural characterization and enantioseparation of the chiral compound praziquantel. Liu Y; Wang X; Wang JK; Ching CB J Pharm Sci; 2004 Dec; 93(12):3039-46. PubMed ID: 15514924 [TBL] [Abstract][Full Text] [Related]
4. Solubility properties of racemic praziquantel and its enantiomers. el-Arini SK; Giron D; Leuenberger H Pharm Dev Technol; 1998 Nov; 3(4):557-64. PubMed ID: 9834959 [TBL] [Abstract][Full Text] [Related]
5. Enantiomeric 3-chloromandelic acid system: binary melting point phase diagram, ternary solubility phase diagrams and polymorphism. Le Minh T; von Langermann J; Lorenz H; Seidel-Morgenstern A J Pharm Sci; 2010 Sep; 99(9):4084-95. PubMed ID: 20575001 [TBL] [Abstract][Full Text] [Related]
6. Solubility of molecular crystals: polymorphism in the light of solubility theory. Bennema P; van Eupen J; van der Wolf BM; Los JH; Meekes H Int J Pharm; 2008 Mar; 351(1-2):74-91. PubMed ID: 17980982 [TBL] [Abstract][Full Text] [Related]
7. Solubility, metastable zone width, and racemic characterization of propranolol hydrochloride. Wang X; Wang XJ; Ching CB Chirality; 2002 May; 14(4):318-24. PubMed ID: 11968072 [TBL] [Abstract][Full Text] [Related]
8. Discovery of a solid solution of enantiomers in a racemate-forming system by seeding. Huang J; Chen S; Guzei IA; Yu L J Am Chem Soc; 2006 Sep; 128(36):11985-92. PubMed ID: 16953640 [TBL] [Abstract][Full Text] [Related]
9. Anion effect on the binary and ternary phase diagrams of chiral medetomidine salts and conglomerate crystal formation. Choobdari E; Fakhraian H; Peyrovi MH Chirality; 2014 Mar; 26(3):183-8. PubMed ID: 24574075 [TBL] [Abstract][Full Text] [Related]
10. Application of direct crystallization for racemic compound propranolol hydrochloride. Wang X; Lu J; Ching CB J Pharm Sci; 2007 Oct; 96(10):2735-45. PubMed ID: 17549769 [TBL] [Abstract][Full Text] [Related]
11. The solubility behaviour and thermodynamic relations of the three forms of Venlafaxine free base. van Eupen JT; Westheim R; Deij MA; Meekes H; Bennema P; Vlieg E Int J Pharm; 2009 Feb; 368(1-2):146-53. PubMed ID: 18996456 [TBL] [Abstract][Full Text] [Related]
12. Solid-state properties and crystallization behavior of PHA-739521 polymorphs. Sun CC Int J Pharm; 2006 Aug; 319(1-2):114-20. PubMed ID: 16720086 [TBL] [Abstract][Full Text] [Related]
13. Modeling and prediction of cocrystal phase diagrams. Ainouz A; Authelin JR; Billot P; Lieberman H Int J Pharm; 2009 Jun; 374(1-2):82-9. PubMed ID: 19446763 [TBL] [Abstract][Full Text] [Related]
14. Crystal structure, thermal behavior and enzymatic degradation of poly(tetramethylene adipate) solution-grown chain-folded lamellar crystals. Iwata T; Kobayashi S; Tabata K; Yonezawa N; Doi Y Macromol Biosci; 2004 Mar; 4(3):296-307. PubMed ID: 15468220 [TBL] [Abstract][Full Text] [Related]
15. Theoretical and experimental study of a praziquantel and beta-cyclodextrin inclusion complex using molecular mechanic calculations and H1-nuclear magnetic resonance. de Jesus MB; de Matos Alves Pinto L; Fraceto LF; Takahata Y; Lino AC; Jaime C; de Paula E J Pharm Biomed Anal; 2006 Jun; 41(4):1428-32. PubMed ID: 16678375 [TBL] [Abstract][Full Text] [Related]
16. Melting point and phase diagram of methanol as obtained from computer simulations of the OPLS model. Gonzalez Salgado D; Vega C J Chem Phys; 2010 Mar; 132(9):094505. PubMed ID: 20210403 [TBL] [Abstract][Full Text] [Related]
17. [Influence of mobile phase composition on chiral separation of albendazole sulfoxide racemates]. Zhai Z; Zhang H; Dun H; Liu C; Chen L; Li Y Se Pu; 2004 May; 22(3):244-7. PubMed ID: 15712908 [TBL] [Abstract][Full Text] [Related]
18. Study of the characterization and crystallization of 4-hydroxy-2-pyrrolidone. Wang XJ; Wiehler H; Ching CB Chirality; 2004 May; 16(4):220-7. PubMed ID: 15034904 [TBL] [Abstract][Full Text] [Related]
19. Preferential enrichment: full crystallographic analysis of the unusual phenomenon in the mixed crystals' version. Takahashi H; Tamura R; Fujimoto D; Lepp Z; Kobayashi K; Ushio T Chirality; 2002 Jul; 14(7):541-7. PubMed ID: 12112325 [TBL] [Abstract][Full Text] [Related]
20. Variable-temperature X-ray powder diffraction analysis of the crystal transformation of the pharmaceutically preferred polymorph C of mebendazole. de Villiers MM; Terblanche RJ; Liebenberg W; Swanepoel E; Dekker TG; Song M J Pharm Biomed Anal; 2005 Jul; 38(3):435-41. PubMed ID: 15925244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]